PATH’s new Vaccine Cost Calculators for pneumococcal conjugate vaccine (PCV) and rotavirus vaccine aim to help country-level decision-makers specifically in middle-income countries compare products and estimate vaccination program costs for different vaccine options. Both calculators are available in English, French, and Spanish. A six-minute video providing a brief tutorial on using the calculators is also available in English, French, and Spanish.
PATH launched an initial set of Vaccine Cost Calculators in 2020 that were designed to be useable by any country, whether or not they were eligible for support from Gavi, the Vaccine Alliance. However, we realized that the needs of middle-income countries differed from those of Gavi-eligible countries, and that more flexible tools tailored to their unique needs would be helpful.
The new calculators enable users to compare the estimated cold chain volume and financial costs of PCV or rotavirus vaccination programs with each vaccine product available in the global market (including those no longer offered to Gavi-eligible countries) annually and for a total period of five years. Users also can add a domestically produced vaccine option that is not available in the global market, as well as compare costs for up to three different scenarios of multi-vaccine use since some countries may plan to use more than one product at the same time.
For questions or support, contact PATH’s Health Economics & Outcomes Research team: HEOR@path.org.
Any organization or individual working in the field of immunization economics can submit findings, opportunities, calls to action, or other relevant work below to be shared with our community.